retatrutide clinical trial data Phase 3: TRIUMPH Program Results 2026 Retatrutide TRIUMPH-1 Results: 28% Weight

what we eat, listen to and watch

Retatrutide's GIP component improves tolerability and insulin sensitivity

Source Reference: Bliddal H, et al "Once-weekly semaglutide in persons with obesity and knee osteoarthritis" N Engl J Med 2024

Thanks to Amble, it was affordable and accessible

Table of Contents: Is Mounjaro the same as Ozempic when it comes to weight loss results

Decision factors: Weight loss goals: Want maximum weight loss and can tolerate side effects: Tirzepatide (Zepbound) shows ~4% greater weight loss than semaglutide on average Want proven cardiovascular benefits: Semaglutide has demonstrated 20% reduction in major cardiovascular events in the SELECT trial Want to try oral option: Oral semaglutide (Rybelsus) for diabetes, though weight loss is less than injectable Side effect sensitivity: Some people tolerate one better than the other